Resource Center

Oct 1, 2014

Isoxazolotacrines as non-toxic and selective butyrylcholinesterase inhibitors for Alzheimer’s disease

Background

Owing to the complex nature of Alzheimer’s disease, there is a renewed and growing search for multitarget non-toxictacrines as simple, easily available drugs in order to stop the progress and development of the disease.

Contact Us About This Journal Article